EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors

Valentina Evdokimova, Peter Ruzanov, Hendrik Gassmann, Minsheng Hung, Zhenbo Zhang, Andrea Senff-Ribeiro, Naghmeh Khoshgoo, Suky Zheng, Manideep C Pachva, Emily M Ringwalt, Timothy P Cripe, Ryan D Roberts und 4 weitere

Cell Reports · 2026-07 · 45 (7) · 117708

DOI: 10.1016/j.celrep.2026.117708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Valentina Evdokimova und 15 weiteren Autor:innen. Beteiligte Einrichtung: Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada. Electronic address: v.evdokimova@gmail.com. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Signal Transduction, Reverse Transcriptase Inhibitors, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingSignal TransductionReverse Transcriptase InhibitorsInflammationHumansCell Line, TumorProto-Oncogene Protein c-fli-1NF-kappa BEndogenous RetrovirusesOncogene Proteins, FusionRNA-Binding Protein EWSLong Interspersed Nucleotide ElementsExtracellular VesiclesCytokinesSTAT3 Transcription Factor

Stichwörter der Autor:innen

CP: cancerEwing sarcomaHERV-KIFN-ILINE-1NFkBSTAT3TBK1cGAScytokinesendogenous retroelementextracellular vesiclesinflammationreverse transcriptase

Substanzen

Reverse Transcriptase InhibitorsProto-Oncogene Protein c-fli-1NF-kappa BOncogene Proteins, FusionRNA-Binding Protein EWSCytokinesSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada. Electronic address: v.evdokimova@gmail.com.
  • Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
  • Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing and Institute of Pathology, 80804 Munich, Germany; Institute of Pathology, TUM School of Medicine and Health, Technical Univers…
  • Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA; Division of Pediatric Hematology, Oncology, and BMT, Nationwide Children's Hospital, Columbus, O…

Förderung

  • NCI NIH HHS
  • NCI

Zitieren

APA

Evdokimova, V., Ruzanov, P., Gassmann, H., Hung, M., Zhang, Z., Senff-Ribeiro, A., Khoshgoo, N., Zheng, S., Pachva, M. C., Ringwalt, E. M., Cripe, T. P., Roberts, R. D., Sorensen, P. H., Burdach, S. E. G., Stein, L. D., & Radvanyi, L. (2026). Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors. Cell Reports, 45(7), 117708. https://doi.org/10.1016/j.celrep.2026.117708

Vancouver

Evdokimova V, Ruzanov P, Gassmann H, Hung M, Zhang Z, Senff-Ribeiro A, et al. Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors. Cell Reports. 2026;45(7):117708. doi:10.1016/j.celrep.2026.117708

BibTeX
@article{Evdokimova2026,
  author = {Evdokimova, Valentina and Ruzanov, Peter and Gassmann, Hendrik and Hung, Minsheng and Zhang, Zhenbo and Senff-Ribeiro, Andrea and Khoshgoo, Naghmeh and Zheng, Suky and Pachva, Manideep C and Ringwalt, Emily M and Cripe, Timothy P and Roberts, Ryan D and Sorensen, Poul H and Burdach, Stefan E G and Stein, Lincoln D and Radvanyi, Laszlo},
  title = {Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117708},
  doi = {10.1016/j.celrep.2026.117708}
}
Kostenlos starten →